The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry

August 30, 2023 updated by: University of Nebraska
The purpose of this registry is to create a database that collects clinical data to improve knowledge about primary hyperparathyroidism.

Study Overview

Status

Completed

Detailed Description

This will be a multi-institutional prospective study in which patients that have undergone parathyroidectomy with intra-operative PTH assessment. The success of minimally invasive parathyroidectomy without and with intra-operative PTH will be assessed for each patient. Success for exploration without intra-operative PTH will be defined as directed exploration with detection of an abnormal parathyroid in the location suggested by imaging. Success with intra-operative PTH will be defined as per standard protocols (50% or > decrease in intra-operative PTH following excision).

Study Type

Observational

Enrollment (Actual)

175

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Iowa
      • Iowa City, Iowa, United States, 52242
        • University of Iowa
    • Kansas
      • Lawrence, Kansas, United States, 66160
        • Kansas University Medical Center
    • Minnesota
      • Minneapolis, Minnesota, United States, 55414
        • University of Minnesota
    • Missouri
      • Columbia, Missouri, United States, 65212
        • University Of Missiouri
    • Nebraska
      • Omaha, Nebraska, United States, 681225
        • University of Nebraska Medical Center
    • South Dakota
      • Sioux Falls, South Dakota, United States, 57105
        • Sanford School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Otolaryngology, Head and Neck Surgery clinic patients

Description

Inclusion Criteria:

  • Adult individuals (male and female) who have a personal diagnosis/history of primary hyperparathyroidism.
  • Age 19 or greater.
  • Patients who are seen and treated surgically at UNMC's Department of Otolaryngology- Head Neck Surgery .
  • Able to provide informed consent.

Exclusion Criteria:

-No history of primary hyperparathyroidism

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Russell B Smith, MD, University of Nebraska

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 9, 2010

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

April 27, 2015

Study Registration Dates

First Submitted

August 2, 2011

First Submitted That Met QC Criteria

August 2, 2011

First Posted (Estimated)

August 4, 2011

Study Record Updates

Last Update Posted (Actual)

September 6, 2023

Last Update Submitted That Met QC Criteria

August 30, 2023

Last Verified

August 1, 2023

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Primary Hyperparathyroidism

3
Subscribe